Repligen (RGEN) to Acquire Engineered Molding Technology

Go back to Repligen (RGEN) to Acquire Engineered Molding Technology

Repligen Announces Agreement to Acquire Engineered Molding Technology

June 29, 2020 7:30 AM UTC

WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Albany, New York based Engineered Molding Technology (EMT), an innovator and manufacturer of single-use silicone assemblies and components used in the manufacturing of biologic drugs. EMTs standard and custom molded and over-molded connectors and silicone tubing products are key components in single-use filtration and chromatography systems.

Tony J. Hunt, President and CEO of Repligen, said, The acquisition of EMT expands our line of single-use... More